000 01214 a2200337 4500
005 20250513184754.0
264 0 _c19990709
008 199907s 0 0 eng d
022 _a0140-6736
024 7 _a10.1016/S0140-6736(99)01443-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWilson, A M
245 0 0 _aImportance of drug-device interaction in determining systemic effects of inhaled corticosteroids.
_h[electronic resource]
260 _bLancet (London, England)
_cJun 1999
300 _a2128 p.
_bdigital
500 _aPublication Type: Clinical Trial; Letter; Randomized Controlled Trial
650 0 4 _aAndrostadienes
_xadministration & dosage
650 0 4 _aAnti-Inflammatory Agents
_xadministration & dosage
650 0 4 _aBiological Availability
650 0 4 _aCross-Over Studies
650 0 4 _aEquipment Design
650 0 4 _aFluticasone
650 0 4 _aHumans
650 0 4 _aNebulizers and Vaporizers
700 1 _aDempsey, O J
700 1 _aCoutie, W J
700 1 _aSims, E J
700 1 _aLipworth, B J
773 0 _tLancet (London, England)
_gvol. 353
_gno. 9170
_gp. 2128
856 4 0 _uhttps://doi.org/10.1016/S0140-6736(99)01443-9
_zAvailable from publisher's website
999 _c10341059
_d10341059